| Literature DB >> 29767113 |
Manhu Cao1, Rejun Fang1, Juan Chen1, Jianhua He1.
Abstract
The objective of the study was to determine the role of vitamin D3 (VD3) in regulating adaptation and mechanism ofEntities:
Keywords: 1,25-(OH)2D3; 1α-hydroxylase; CYP27B1; Low-phosphorus; Na/Pi-Ⅱb
Year: 2016 PMID: 29767113 PMCID: PMC5941033 DOI: 10.1016/j.aninu.2016.06.001
Source DB: PubMed Journal: Anim Nutr ISSN: 2405-6383
Composition and nutrient levels of the basal diets (air-dry basis).
| Item | Treatments | |||
|---|---|---|---|---|
| 0.2% P | 0.4% P | 0.6% P | 0.8% P | |
| Ingredients, % | ||||
| Corn starch | 60 | 60 | 60 | 60 |
| Soybean meal | 34 | 34 | 34 | 34 |
| Lysine·HCl | 0.3 | 0.3 | 0.3 | 0.3 |
| Limestone | 0.5 | 0.5 | 0.5 | 0.5 |
| CaHPO4·2H2O | 0 | 1.17 | 2.34 | 3.51 |
| Choline | 0.25 | 0.25 | 0.25 | 0.25 |
| NaCl | 0.3 | 0.3 | 0.3 | 0.3 |
| Vitamin premix | 0.1 | 0.1 | 0.1 | 0.1 |
| Mineral premix | 0.1 | 0.1 | 0.1 | 0.1 |
| Zeolite powder | 4.45 | 3.28 | 2.11 | 0.94 |
| Total | 100 | 100 | 100 | 100 |
| Nutrient levels | ||||
| DE, MJ/kg | 13.81 | 13.81 | 13.81 | 13.81 |
| CP | 15 | 15 | 15 | 15 |
| Ca | 0.28 | 0.55 | 0.82 | 1.09 |
| P | 0.2 | 0.4 | 0.6 | 0.8 |
| Lysine | 1.2 | 1.2 | 1.2 | 1.2 |
| Ca:P | 1.33:1 | 1.37:1 | 1.36:1 | 1.36:1 |
Provided the following for per kilogram diet: vitamin A, 7,000 IU; vitamin E, 5 mg; vitamin K, 5 mg; vitamin B complex, 110 mg; biotin, 0.2 mg; folic acid, 6 mg.
Provided the following for per kilogram diet: iron, 120 mg; copper, 8 mg; zinc, 30 mg; manganese, 75 mg; selenium, 0.05 mg; iodine, 0.05 mg.
The DE is calculated value, Other indicators are measured value.
The sequences, amplified regions and fragment length of Na/Pi-IIb and CYP27B1 primers.
| Primer name | Sequences of the primer pair | Fragment length, bp |
|---|---|---|
| 5′-CGTCCTCGTCAATCATCGTCAG-3′ | 123 | |
| 5′-GCATAAGTGCCACAATCGTGTT-3′ | ||
| 5′-TCTGAGAGTGCTGATGTACCTAAGT-3′ | 120 | |
| 5′-AGGTACTCATCCAACACCAGGTAT-3′ | ||
| 5′-TGCCTTAAGAGTGGAGCCATATGT-3′ | 118 | |
| 5′-TTGGTTTACATGTCGCACGTCTC-3′ | ||
| β-actin sense | 5′-CCGTAAAGACCTCTATGCCAACA-3′ | 113 |
| β-actin antisense | 5′-GCTAGGAGCCAGGGCAGTAATCT-3′ |
Na/Pi-Ⅱb = sodium phosphate co-transporter type Ⅱb; CYP27B1 = 25-hydroxyvitamin D 1-α hydroxylase.
The primers were designed using Primer Expression software Primer Premier 5.
Dietary P levels and vitamin D3 (VD3) affected Ca and P concentrations of bone and serum.1
| Item | 0.2% P | 0.4% P | 0.6% P | 0.8% P | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C | R | I | C | R | I | C | R | I | C | R | I | SEM | Dietary P | VD3 | Dietary P × VD3 | |
| Bone | ||||||||||||||||
| Ca, mg/100 g | 76.6 | 40.1* | 33.3* | 79.7 | 32.0* | 34.0* | 105.6 | 115.8 | 64.4* | 116.1 | 119.4 | 84.7* | 3.27 | <0.001 | <0.001 | <0.001 |
| P, mg/100 g | 48.7 | 34.7* | 34.8* | 52.9 | 32.3* | 39.2* | 72.7 | 254.5* | 245.5* | 76.5 | 247.6* | 246.0* | 2.43 | <0.001 | <0.001 | <0.001 |
| Serum | ||||||||||||||||
| Ca, mg/L | 86.6 | 42.4* | 42.2* | 86.6 | 51.5* | 52.9* | 92.1 | 44.4* | 51.4* | 99.4 | 41.7* | 49.3* | 2.98 | 0.038 | <0.001 | 0.062 |
| P, mg/L | 81.4 | 77.7 | 92.4 | 79.7 | 114.4※ | 91.0 | 96.1 | 92.4 | 96.4 | 99.5 | 90.1 | 99.9 | 5.90 | 0.045 | 0.36 | 0.008 |
| VD3, μg/L | 9.3 | 3.9* | 11.9* | 8.6 | 2.9* | 10.9* | 7.1 | 2.7* | 9.1* | 8.1 | 2.7* | 9.9* | 0.11 | <0.001 | <0.001 | <0.001 |
| 1α-hydroxylase, mU/mg prot | 108.4 | 84.7* | 135.4* | 112.5 | 91.2* | 122.6* | 94.8 | 95.3 | 102.6* | 105.8 | 102.4 | 111.5* | 0.63 | <0.001 | <0.001 | <0.001 |
| FGF23, μg/L | 20.1 | 20.4 | 24.9※ | 19.5 | 21.2 | 25.9※ | 23.6 | 23.9 | 25.4 | 24.8 | 22.4 | 24.3 | 3.02 | 0.035 | 0.016 | <0.001 |
FGF23 = fibroblast growth factor 23.
Data are means of 6 replicates per treatment. C represents control group; R represents restricted VD3 group; I represents group injected with VD3. “※” or “*” means are different from the C group at ※P < 0.01 and *P < 0.01.
Fig. 1Effects of dietary P (0.2%, 0.4%, 0.6% or 0.8%) and Vitamin D3 (VD3) on Na/Pi-Ⅱb mRNA level in ileum (A), jejunum (B), duodenum (C) and kidneys (D) of rats. Data are means of 6 replicates per treatment. C represents control group; R represents restricted VD3 group; I represents group injected with VD3. “※” and “*” indicate that means are different from that of the C group at ※P < 0.05, ※※P < 0.01 and *P < 0.001.
Fig. 2Effect of dietary P (0.2%, 0.4%, 0.6% or 0.8%) and Vitamin D3 (VD3) on CYP27B1 mRNA level in kidneys. Data are means of 6 replicates per treatment. C represents control group; R represents restricted vitamin D group; I represents group injected with VD3. “※” and “∗” indicate that means are different from that of the C group at ※P < 0.05, ※※P < 0.01 and *P < 0.001.
Fig. 3Effects of dietary P (0.2%, 0.4%, 0.6% or 0.8%) and Vitamin D3 (VD3) on P absorption in ileum (A), jejunum (B), duodenum (C) and kidneys (D) of rats. Data are means of 6 replicates per treatment. C represents control group; R represents restricted vitamin D group; I represents group injected with VD3. “※” and “*” indicate that means are different from that of the C group at ※P < 0.05, ※※P < 0.01 and *P < 0.001.